Trevi Therapeutics Inc (NASDAQ:TRVI)
| 2.84 BATS BZX Real-Time Price As of 10:09am ET |  -0.02 / -0.70%Today’s Change | 1.33 Today|||52-Week Range 8.50 | +17.36% Year-to-Date |
Latest TRVI News | Press Releases
No recent news for Trevi Therapeutics Inc.
Today’s Trading
| Previous close | 2.86 |
| Today’s open | 2.89 |
| Day’s range | 2.81 - 2.89 |
| Volume | 400 |
| Average volume (3 months) | 83,768 |
| Market cap | $56.2M |
Data as of 10:09am ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -58.40% |
| Earnings growth (this year) | +25.93% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGLSRegulus Therapeutics... | -0.03 | -2.34% |
| NBRVNabriva Therapeutics... | -0.13 | -5.37% |
| CPIXCumberland Pharmaceu... | -0.03 | -0.89% |
| GWPDGP Solutions Inc | -1.24 | -68.89% |
Data as of 10:25am ET, 02/26/2021
Financials
| Next reporting date | March 22, 2021 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$26.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
